67 results
Page 2 of 4
8-K
EX-10.1
9gn8h22 6crav44p7
1 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
snm3di8ao 0v3l
1 Sep 15
Matinas BioPharma Appoints Cochleate Technology Pioneer Raphael J. Mannino, Ph.D., as Senior Vice President and Chief Technology Officer
12:00am
POS AM
EX-10.21
ckfrdgcbj7l0
17 Apr 15
Prospectus update (post-effective amendment)
12:00am
POS AM
EX-10.20
l3d jgpllrah
17 Apr 15
Prospectus update (post-effective amendment)
12:00am
10-K
EX-10.6
pg02 ocsq4l
31 Mar 15
Annual report
12:00am
S-8
EX-10.1
bqx5 4yay
31 Mar 15
Registration of securities for employees
12:00am
10-K
EX-10.18
45mn7nhl8x
31 Mar 15
Annual report
12:00am
8-K
EX-10.1
x5atig6dftbkq1acod
18 Mar 15
Departure of Directors or Certain Officers
12:00am
S-8
EX-10.1
2sz exrwlif
29 Aug 14
Registration of securities for employees
12:00am
S-1/A
EX-10.7
cvsi83weyu
7 Feb 14
IPO registration (amended)
12:00am
S-1/A
EX-10.16
58zmuwjy33yl
7 Feb 14
IPO registration (amended)
12:00am
S-1/A
EX-10.3
kyodnhlu
7 Feb 14
IPO registration (amended)
12:00am
S-1/A
EX-10.6
22a12izdsa7dn7n 2ee
7 Feb 14
IPO registration (amended)
12:00am
S-1/A
EX-10.14
oqijv k72
7 Feb 14
IPO registration (amended)
12:00am
S-1/A
EX-10.1
yk1n qno9dfnpsu
7 Feb 14
IPO registration (amended)
12:00am
S-1/A
EX-10.8
c8v b8o2c1hne2
7 Feb 14
IPO registration (amended)
12:00am